1. Home
  2. PDEX vs CRDL Comparison

PDEX vs CRDL Comparison

Compare PDEX & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDEX
  • CRDL
  • Stock Information
  • Founded
  • PDEX 1978
  • CRDL 2017
  • Country
  • PDEX United States
  • CRDL Canada
  • Employees
  • PDEX N/A
  • CRDL N/A
  • Industry
  • PDEX Medical/Dental Instruments
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PDEX Health Care
  • CRDL Health Care
  • Exchange
  • PDEX Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • PDEX 152.3M
  • CRDL 126.5M
  • IPO Year
  • PDEX N/A
  • CRDL N/A
  • Fundamental
  • Price
  • PDEX $33.65
  • CRDL $1.10
  • Analyst Decision
  • PDEX Strong Buy
  • CRDL Strong Buy
  • Analyst Count
  • PDEX 1
  • CRDL 2
  • Target Price
  • PDEX $56.00
  • CRDL $9.00
  • AVG Volume (30 Days)
  • PDEX 35.9K
  • CRDL 706.5K
  • Earning Date
  • PDEX 10-30-2025
  • CRDL 11-13-2025
  • Dividend Yield
  • PDEX N/A
  • CRDL N/A
  • EPS Growth
  • PDEX 345.00
  • CRDL N/A
  • EPS
  • PDEX 2.67
  • CRDL N/A
  • Revenue
  • PDEX $66,593,000.00
  • CRDL N/A
  • Revenue This Year
  • PDEX $7.22
  • CRDL N/A
  • Revenue Next Year
  • PDEX N/A
  • CRDL N/A
  • P/E Ratio
  • PDEX $12.45
  • CRDL N/A
  • Revenue Growth
  • PDEX 23.68
  • CRDL N/A
  • 52 Week Low
  • PDEX $23.68
  • CRDL $0.77
  • 52 Week High
  • PDEX $70.26
  • CRDL $2.44
  • Technical
  • Relative Strength Index (RSI)
  • PDEX 33.63
  • CRDL 46.01
  • Support Level
  • PDEX $31.72
  • CRDL $1.06
  • Resistance Level
  • PDEX $35.00
  • CRDL $1.10
  • Average True Range (ATR)
  • PDEX 2.03
  • CRDL 0.06
  • MACD
  • PDEX -0.80
  • CRDL 0.01
  • Stochastic Oscillator
  • PDEX 11.96
  • CRDL 44.12

About PDEX Pro-Dex Inc.

Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: